Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: The Breast Cancer Health Disparities Study

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 770, Issue , 2014, Pages 19-28

  Slattery, Martha L ^a   Lundgreen, Abbie ^a   Torres Mejia, Gabriela ^b   Wolff, Roger K ^a   Hines, Lisa ^c   Baumgartner, Kathy ^d   John, Esther M ^e,f  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e Cancer Prevention Institute of California   (United States)

^f STANFORD CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Cigarettes; Oxidative stress; Survival; TLR; TNF; TRAF2; TRAIL

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; NONSTEROID ANTIINFLAMMATORY AGENT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A; UNCLASSIFIED DRUG;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DIET; DRUG USE; FEMALE; GENE; GENETIC ASSOCIATION; HISPANIC; HUMAN; IMMUNE RESPONSE GENE; INFLAMMATION; INFLAMMATORY RESPONSE GENE; LIFESTYLE; MAJOR CLINICAL STUDY; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; BREAST TUMOR; CASE CONTROL STUDY; DISEASE PREDISPOSITION; ETHNIC GROUP; ETHNOLOGY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEALTH DISPARITY; IMMUNITY; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGICAL STRESS; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIET; DISEASE SUSCEPTIBILITY; ETHNIC GROUPS; FEMALE; GENE-ENVIRONMENT INTERACTION; HEALTH STATUS DISPARITIES; HUMANS; IMMUNITY; INFLAMMATION; LIFE STYLE; MIDDLE AGED; RISK FACTORS; STRESS, PHYSIOLOGICAL;

EID: 84908054089     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2014.08.009     Document Type: Article

References (49)

1. Gao Z., Zuberi A., Quon M.J., Dong Z., Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J. Biol. Chem. 2003, 278:24944-24950.
2. Xu H., Hotamisligil G.S. Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett. 2001, 506:97-102.
3. Hotamisligil G.S. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 1999, 245:621-625.
4. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
5. Hofmann C., Lorenz K., Braithwaite S.S., Colca J.R., Palazuk B.J., et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994, 134:264-270.
6. Kuribayashi K., Krigsfeld G., Wang W., Xu J., Mayes P.A., et al. TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death. Cancer Biol. Ther. 2008, 7:2034-2038.
7. Fukata M., Abreu M.T. TLR4 signalling in the intestine in health and disease. Biochem. Soc. Trans. 2007, 35:1473-1478.
8. Resler A.J., Malone K.E., Johnson L.G., Malkki M., Petersdorf E.W., et al. Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC Cancer 2013, 13:219.
9. Mai C.W., Kang Y.B., Pichika M.R. Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther. 2013, 6:1573-1587.
10. Simiantonaki N., Kurzik-Dumke U., Karyofylli G., Jayasinghe C., Michel-Schmidt R., et al. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int. J. Mol. Med. 2007, 20:21-29.
11. Niedzielska I., Niedzielski Z., Tkacz M., Orawczyk T., Ziaja K., et al. Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer. J. Physiol. Pharmacol. 2009, 60(Suppl. 1):65-71.
12. Gomez Flores-Ramos L., Escoto-De Dios A., Puebla-Perez A.M., Figuera-Villanueva L.E., Ramos-Silva A., et al. Association of the tumor necrosis factor-alpha -308G>A polymorphism with breast cancer in Mexican women. Genet. Mol. Res. 2013, 12:5680-5693.
13. Slattery M.L., John E.M., Torres-Mejia G., Lundgreen A., Herrick J.S., et al. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 2012, 33:1512-1521.
14. Slattery M.L., John E.M., Torres-Mejia G., Lundgreen A., Lewinger J.P., et al. Angiogenesis genes, dietary oxidative balance, and breast cancer risk and progression: the breast cancer health disparities study. Int. J. Cancer 2013, 134:629-644.
15. Slattery M.L., Sweeney C., Edwards S., Herrick J., Baumgartner K., et al. Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res. Treat. 2007, 102:85-101.
16. Angeles-Llerenas A., Ortega-Olvera C., Perez-Rodriguez E., Esparza-Cano J.P., Lazcano-Ponce E., et al. Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control 2010, 21:577-586.
17. John E.M., Horn-Ross P.L., Koo J. Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1143-1152.
18. John E.M., Phipps A.I., Davis A., Koo J. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2905-2913.
19. Slattery M.L., Caan B.J., Duncan D., Berry T.D., Coates A., et al. A computerized diet history questionnaire for epidemiologic studies. J. Am. Diet. Assoc. 1994, 94:761-766.
20. Murtaugh M.A., Sweeney C., Giuliano A.R., Herrick J.S., Hines L., et al. Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am. J. Clin. Nutr. 2008, 87:978-984.
21. Hernandez-Avila M., Romieu I., Parra S., Hernandez-Avila J., Madrigal H., et al. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex. 1998, 40:133-140.
22. Horn-Ross P.L., John E.M., Lee M., Stewart S.L., Koo J., et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am. J. Epidemiol. 2001, 154:434-441.
23. Falush D., Stephens M., Pritchard J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003, 164:1567-1587.
24. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.
25. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 2004, 74:765-769.
26. Li J., Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005, 95:221-227.
27. Yu K., Li Q., Bergen A.W., Pfeiffer R.M., Rosenberg P.S., et al. Pathway analysis by adaptive combination of P-values. Genet. Epidemiol. 2009, 33:700-709.
28. Yu K., Li Q., Wheeler W. ARTP Gene and Pathway p-Values Computed using the Adaptive Rank Truncated Product 2011, R Package. 2.0.0 ed.
29. Shatz M., Menendez D., Resnick M.A. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Res. 2012, 72:3948-3957.
30. Yang H., Zhou H., Feng P., Zhou X., Wen H., et al. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J. Exp. Clin. Cancer Res. 2010, 29:92.
31. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007, 13:1050-1059.
32. Salaun B., Coste I., Rissoan M.C., Lebecque S.J., Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J. Immunol. 2006, 176:4894-4901.
33. Fejerman L., Stern M.C., Ziv E., John E.M., Torres-Mejia G., et al. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women. Carcinogenesis 2013, 34:1787-1793.
34. Barnholtz-Sloan J.S., Shetty P.B., Guan X., Nyante S.J., Luo J., et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 2010, 31:1417-1423.
35. Wu Y., Zhou B.P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 2010, 102:639-644.
36. Guo J., Meng H., Pei J., Zhu M. Association between the TNF-alpha-238G>A and TGF-beta1 L10P polymorphisms and breast cancer risk: a meta-analysis. Breast Care (Basel) 2011, 6:126-129.
37. Bisgin A., Kargi A., Yalcin A.D., Aydin C., Ekinci D., et al. Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC Cancer 2012, 12:58.
38. Rahman M., Pumphrey J.G., Lipkowitz S. The TRAIL to targeted therapy of breast cancer. Adv. Cancer Res. 2009, 103:43-73.
39. Thorburn A., Behbakht K., Ford H. TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resist. Updat. 2008, 11:17-24.
40. Rahman M., Davis S.R., Pumphrey J.G., Bao J., Nau M.M., et al. TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res. Treat. 2009, 113:217-230.
41. Kim S., Moon S.M., Kim Y.S., Kim J.J., Ryu H.J., et al. TNFR1 promoter -329G/T polymorphism results in allele-specific repression of TNFR1 expression. Biochem. Biophys. Res. Commun. 2008, 368:395-401.
42. Bou Khzam L., Hachem A., Zaid Y., Boulahya R., Mourad W., et al. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species. Thromb. Haemost. 2013, 109:940-947.
43. Bou Khzam L., Boulahya R., Abou-Saleh H., Hachem A., Zaid Y., et al. Soluble CD40 ligand stimulates the pro-angiogenic function of peripheral blood angiogenic outgrowth cells via increased release of matrix metalloproteinase-9. PLOS ONE 2013, 8:e84289.
44. Carcamo J.M., Pedraza A., Borquez-Ojeda O., Golde D.W. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 2002, 41:12995-13002.
45. Metcalfe H.J., Lea S., Hughes D., Khalaf R., Abbott-Banner K., et al. Effects of cigarette smoke on TLR activation of COPD macrophages. Clin. Exp. Immunol. 2014, 176:461-472.
46. Bozinovski S., Vlahos R., Zhang Y., Lah L.C., Seow H.J., et al. Carbonylation caused by cigarette smoke extract is associated with defective macrophage immunity. Am. J. Respir. Cell Mol. Biol. 2011, 45:229-236.
47. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424:797-801.
48. Palikhe N.S., Kim S.H., Kim J.H., Losol P., Ye Y.M., et al. Role of Toll-like receptor 3 variants in aspirin-exacerbated respiratory disease. Allergy Asthma Immunol. Res. 2011, 3:123-127.
49. Chatzigeorgiou A., Seijkens T., Zarzycka B., Engel D., Poggi M., et al. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:2686-2691.